Academic Panel of Scientists to Meet With FDA Regarding Avandia Risks
On Monday, July 30, a panel of academic scientists will meeting with the Food
and Drug Administration to discuss how regulators should respond to the
accusation that the diabetes drug Avandia, made by GlaxoSmithKline, increases
the risk for heart attacks in users.
In may, a published paper shocked
patients and the medical community alike with the statement that Avandia
increases the risk of heart attacks in users by 40 percent.
The panel
that is to convene will seek to weigh whether Avandia is safe, doing so by
analyzing all the data available.
If you or a loved one has suffered
cardiac complications after ingesting Avandia, you deserve the guidance of a
knowledgeable drug attorney. Get a free case review by filling out the form
below.
see also:
Patients Switch Meds
Physicians Take Patients off Avandia Medicine, Citing its Heart RisksFearing the Cardiovascular Risks, Doctors Take Patients off Avandia
Actos Study
Study: Actos Drug Controls Blood Sugar Levels Better than AvandiaResearch finds that Actos Drug is better at controling blood
News & Warnings
Avandia Breaking News: Glaxo Warned in 2001 about Misleading MarketingBloomberg News: FDA Warned Glaxo about Avandia Marketing in 2001


